Work

NEO-ERA-01: A multi-center, single-arm, phase II study with neoadjuvant therapy of HAIC (GEMOX) combined with adebrelimab and lenvatinib for resectable intrahepatic cholangiocarcinoma with high-risk recurrence factors.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e16294

Authors: Jianhua Rao, Tao Wang, Jing Huang, Yongquan Chi, Yuan Cheng, Long Zhang, Xuan Xiao, Feipeng Zhu, Yong Yang, Jinguo Xia, Ye Fan, Xiaoxing Mu, Wei Xu, Haipeng Jiang, Ling Lu, Wentao Wang, Feng Cheng, China Liver Cancer Study Group Young Investigators (CLEAP)

Institutions: Jiangsu Province Hospital, West China Hospital of Sichuan University, Ningbo Medical Center Lihuili Hospital, Nanjing General Hospital of Nanjing Military Command, Nanjing University, Nanjing Medical University

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410813346

Cites:

Cited by: 3

Related to: 10